Anti-inflammatory effect of telmisartan in patients with hypertensio
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000009186
- Lead Sponsor
- Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Allergy against telmisartan (2)Secondary hyperuricemia (3)Systolic BP > 180mmHg, or diastolic BP > 110mmHg (4)Patients with ALT or AST more than twice (5)History of cardiovascular disease and stroke in the previous 6 months. (6)Pregnant women (7)Patients who are not recommended for participation in this study by physician in charge with medical reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The levels of blood pressure, blood/urinary sTNFRs, TNFalpha, OPG, Osteopontin, hs-CRP, IL-6 and MCP-1
- Secondary Outcome Measures
Name Time Method The levels of BW, BMI, e-GFR, albuminuria, serum lipid(TC/TG/HDL-C), and HbA1c